Pharmaron Manufacturing Services (US) LLC Applies for DEA Controlled Substance Importer Registration
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
Pharmaron Manufacturing Services (US) LLC has filed an application with the U.S. Drug Enforcement Administration (DEA) to obtain registration as an importer of one or more basic classes of controlled substances. This is a standard regulatory notice published in the Federal Register as required under the Controlled Substances Act (CSA), which mandates public disclosure of such applications. Pharmaron Manufacturing Services (US) LLC is a contract pharmaceutical manufacturing organization. Importation of controlled substances requires DEA authorization, and this application initiates the formal review process. The DEA evaluates applicants based on public interest criteria including need, compliance history, and diversion risk. Interested parties, including competitors and members of the public, have the right to submit comments or request a hearing on this application within the timeframe specified in the Federal Register notice. No approval has been granted at this stage — the notice signals the beginning of the review period.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Pharmaron Manufacturing Services (US) LLC has formally applied to the DEA for importer registration for basic class(es) of controlled substances as of March 30, 2026.
- Application triggers a mandatory public comment and hearing-request period under 21 CFR Part 1301.
- No import authorization has been granted yet; this notice initiates the regulatory review process.
+ 3 more changes with Pro
Obligations
What this law requires
Pharmaron Manufacturing Services (US) LLC must obtain DEA registration as an importer of controlled substances before importing any basic class(es) of controlled substance(s)
Pharmaron Manufacturing Services (US) LLC must submit a complete application to the DEA that includes evaluation criteria such as compliance history, diversion risk assessment, and demonstration of public interest need
The DEA must publish notice of the application in the Federal Register as required by the Controlled Substances Act
Interested parties, including competitors and members of the public, must submit any comments or hearing requests within the timeframe specified in the Federal Register notice
Pharmaron Manufacturing Services (US) LLC must not import any controlled substances until DEA registration approval is granted